The Impact of Glucocorticoid Therapy on Guideline-Directed Medical Treatment Titration in Patients Hospitalized for Heart Failure with Low Blood Pressure: A Retrospective Study

References

• Peri-Okonny PA, Mi X, Khariton Y, et al. Target doses of heart failure medical therapy and blood pressure: insights from the CHAMP-HF registry. JACC Heart Fail. 2019;7(4):350–358.
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Vaduganathan M, Ambrosy A, et al. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev. 2013;18(2):107–122.
   PubMed Web of Science ®Google Scholar
• Verbrugge FH, Dupont M, Finucan M, et al. Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure. Eur J Heart Fail. 2015;17(9):956–963.
   PubMed Web of Science ®Google Scholar
• Greene SJ, Fonarow GC, DeVore AD, et al. Titration of medical therapy for heart failure with reduced ejection fraction. J Am Coll Cardiol. 2019;73(19):2365–2383.
   PubMed Web of Science ®Google Scholar
• Henning RJ, Becker H, Vincent JL, Thijs L, Kalter E, Weil MH. Use of methylprednisolone in patients following acute myocardial infarction. Hemodynamic and metabolic effects. Chest. 1981;79(2):186–194.
   PubMed Web of Science ®Google Scholar
• Liakopoulos OJ, Schmitto JD, Kazmaier S, et al. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. Ann Thorac Surg. 2007;84(1):110–118;discussion 118–119.
   PubMed Web of Science ®Google Scholar
• Writing Committee M, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Card iology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240–327.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the Ameri can College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):1810–1852.
   PubMed Web of Science ®Google Scholar
• Liu C, Liu K. Effects of glucocorticoids in potentiating diuresis in heart failure patients with diuretic resistance. J Card Fail. 2014;20(9):625–629.
   PubMed Web of Science ®Google Scholar
• Massari F, Mastropasqua F, Iacoviello M, Nuzzolese V, Torres D, Parrinello G. The glucocorticoid in acute decompensated heart failure: dr Jekyll or Mr Hyde? Am J Emerg Med. 2012;30(3):517e515–510.
   Web of Science ®Google Scholar
• Miro O, Takagi K, Gayat E, et al. CORT-AHF study: effect on outcomes of systemic corticosteroid therapy during early management acute heart failure. JACC Heart Fail. 2019;7(10):834–845.
   PubMed Web of Science ®Google Scholar
• Landínez R, Romero M, Maurice E. Efectos de la prednisona sobre la función renal a corto plazo en pacientes con insuficiencia cardíaca descompensada. [Effect of prednisone on short-term renal function in patients with decompensated heart failure]. Venezolana de Medicina Interna. 2014;30:176–182. Spanish.
   Google Scholar
• Raymond R, Guindy R, Gomaa Y, Estafanos H. Effect of prednisone on refractory decompensated congestive heart failure. Eur J Heart Fail. 2014;16:263.
   Web of Science ®Google Scholar
• Liu C, Chen Y, Kang Y, et al. Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure. J Pharmacol Exp Ther. 2011;339(1):203–209.
   PubMed Web of Science ®Google Scholar
• Liu C, Ge N, Zhai JL, Zhang JX. Dexamethasone-induced diuresis is associated with inhibition of the renin-angiotensin-aldosterone system in rats. Kaohsiung J Med Sci. 2016;32(12):614–619.
   PubMed Web of Science ®Google Scholar
• Liu C, Liu G, Zhou C, Ji Z, Zhen Y, Liu K. Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance. Can J Cardiol. 2007;23(11):865–868.
   PubMed Web of Science ®Google Scholar
• Regolisti G, Antoniotti R, Pastorini G, Fani F, Fiaccadori E. Management of congestion and diuretic resistance in heart failure. Nephrol Point Care. 2016;2(1):e73–e87.
   Google Scholar
• Orvin NJ, Beavers JC, Russell SD. Acute diuretic-sparing effects of Sacubitril-Valsartan: staying in the loop. J Pharm Pract. 2021;8971900211010680. doi:10.1177/0871900211010680
   Web of Science ®Google Scholar
• Javidgonbadi D, Andersson B, Abdon NJ, Schaufelberger M, Östman-smith I. Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy. Open Heart. 2019;6(1):e000963.
   PubMed Web of Science ®Google Scholar
• Moulder JE, Cohen EP, Fish BL. Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors. Int J Radiat Biol. 2014;90(9):762–768.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137–e161.
   PubMed Web of Science ®Google Scholar
• Bozkurt B. Response to Ryan and Parwani: heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs? Circ Heart Fail. 2012;5(6):820–821.
   PubMed Web of Science ®Google Scholar
• Driscoll A, Srivastava P, Toia D, Gibcus J, Hare DL. A nurse-led up-titration clinic improves chronic heart failure optimization of beta-adrenergic receptor blocking therapy - a randomized controlled trial. BMC Res Notes. 2014;9:7.
   Google Scholar
• Poortvliet RK, Blom JW, de Craen AJ, et al. Low blood pressure predicts increased mortality in very old age even without heart failure: the Leiden 85-plus Study. Eur J Heart Fail. 2013;15(5):528–533.
   PubMed Web of Science ®Google Scholar
• Oakley RH, Cruz-Topete D, He BO, et al. Cardiomyocyte glucocorticoid and mineralocorticoid receptors directly and antagonistically regulate heart disease in mice. Sci Signal. 2019;4(1945–0877):577–594.
   Google Scholar
• Rog-Zielinska EA, Thomson A, Kenyon CJ, et al. Glucocorticoid receptor is required for foetal heart maturation. Hum Mol Genet. 2013;22(16):3269–3282.
   PubMed Web of Science ®Google Scholar
• Tecklenberg PL, Mullin EM, Stinson EB, Morrow AG. The effects of massive doses of methylprednisolone on myocardial contractility and peripheral vascular resistance. Am Heart J. 1973;85(2):216–226.
   PubMed Web of Science ®Google Scholar
• Jain P, Armando I, Juorio AV, Barden N, Benicky J, Saavedra JM. Decreased hypothalamic and adrenal angiotensin II receptor expression and adrenomedullary catecholamines in transgenic mice with impaired glucocorticoid receptor function. Neuroendocrinology. 2004;80(3):171–180.
   PubMed Web of Science ®Google Scholar
• Nishimura H, Yoshikawa T, Kobayashi N, et al. Effects of methylprednisolone on hemodynamics and beta-adrenergic receptor signaling in rabbits with acute left ventricular failure. Heart Vessels. 1997;12(2):84–91.
   PubMed Web of Science ®Google Scholar
• Zhu X, Huang Y, Li S, et al. Glucocorticoids reverse diluted hyponatremia through inhibiting arginine vasopressin pathway in heart failure rats. J Am Heart Assoc. 2020;9(10):e014950.
   PubMed Web of Science ®Google Scholar
• Hafezi-Moghadam A, Simoncini T, Yang Z, et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med. 2002;8(5):473–479.
   PubMed Web of Science ®Google Scholar
• Liu B, Zhang TN, Knight JK, Goodwin JE. The glucocorticoid receptor in cardiovascular health and disease. Cells. 2019;8:10.
   Web of Science ®Google Scholar
• Matteo RD, May CN. Glucocorticoid-induced renal vasodilatation is mediated by a direct renal action involving nitric oxide. AM J Physiol. 1997;273(6):R1972–R1979.
   PubMedGoogle Scholar
• Lee SR, Kim HK, Youm JB, et al. Non-genomic effect of glucocorticoids on cardiovascular system. Pflugers Arch. 2012;464(6):549–559.
   PubMed Web of Science ®Google Scholar
• Smets PM, Lefebvre HP, Aresu L, et al. Renal function and morphology in aged Beagle dogs before and after hydrocortisone administration. PLoS One. 2012;7(2):e31702.
   PubMed Web of Science ®Google Scholar
• Gardner DG, Hane S, Trachewsky D, Schenk D, Baxter JD. Atrial natriuretic peptide mRNA is regulated by glucocorticoids invivo. Biochem Biophys Res Commun. 1986;139(3):1047–1054.
   PubMed Web of Science ®Google Scholar
• Gardner DG, Gertz BJ, Deschepper CF, Kim DY. Gene for the rat atrial natriuretic peptide is regulated by glucocorticoids in vitro. J Clin Invest. 1988;82(4):1275–1281.
   PubMed Web of Science ®Google Scholar
• Damjancic P, Vierhapper H. Permissive action of glucocorticoid substitution therapy on the effects of Atrial Natriuretic Peptide (hANP) in patients with adrenocortical insufficiency. Exp Clin Endocrinol Diabetes. 1990;95:315–321.
   Web of Science ®Google Scholar
• Liu C, Guan J, Kang Y, et al. Inhibition of dehydration-induced water intake by glucocorticoids is associated with activation of hypothalamic natriuretic peptide receptor-A in rat. PLoS One. 2010;5(12):e15607.
   PubMed Web of Science ®Google Scholar
• Erkut ZA, Pool C, Swaab DF. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. J Clin Endocrinol Metab. 1998;83(6):2066–2073.
   PubMed Web of Science ®Google Scholar
• Liu RY, Unmehopa UA, Zhou JN, Swaab DF. Glucocorticoids suppress vasopressin gene expression in human suprachiasmatic nucleus. J Steroid Biochem Mol Biol. 2006;98(4–5):248–253.
   PubMed Web of Science ®Google Scholar
• Greenwood M, Greenwood MP, Mecawi AS, et al. Transcription factor CREB3L1 mediates cAMP and glucocorticoid regulation of arginine vasopressin gene transcription in the rat hypothalamus. Mol Brain. 2015;8(1):68.
   PubMed Web of Science ®Google Scholar
• Tokudome S, Sano M, Shinmura K, et al. Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. J Clin Invest. 2009;119(6):1477–1488.
   PubMed Web of Science ®Google Scholar
• Gong R, Latif S, Morris DJ, Brem AS. Co-localization of glucocorticoid metabolizing and prostaglandin synthesizing enzymes in rat kidney and liver. Life Sci. 2008;83(21–22):725–731.
   PubMed Web of Science ®Google Scholar
• Butts KA, Phillips AG. Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area. Int J Neuropsychopharmacol. 2013;16(8):1799–1807.
   PubMed Web of Science ®Google Scholar
• Adcock IM, Mumby S. Glucocorticoids. Handb Exp Pharmacol. 2017;237:171–196.
   PubMedGoogle Scholar